Stocks · Health care · Biological Products, (No Diagnostic Substances)

Relay Therapeutics, Inc.

RLAY Clue Score52

United States Fiscal year ends December CIK 0001812364 Results filed 4 Nov 2026

Add to watchlist

By person

6 insiders · 6 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Sanjiv Patel

President and CEO

—

$872.40K (1) scheduled

−$872.40K

1,557,752

0.7108%

$29.01M

−33.1%

Thomas Catinazzo

Chief Financial Officer

—

$356.67K (3) scheduled

−$356.67K

103,665

0.0473%

$1.93M

−59.4%

Donald A Bergstrom

President, R&D

—

$41.93K (1)

−$41.93K

396,878

0.1811%

$7.39M

−9.9%

Peter Rahmer

See remarks

—

$14.02K (1)

−$14.02K

222,904

0.1017%

$4.15M

−34.7%

SVF Pauling (Cayman) Ltd entity

10% owner

—

21,904,963

10.00%

$407.87M

−21.5%

Brian Adams

Chief Legal Officer

—

371,472

0.1695%

$6.92M

+15.4%

Relay Therapeutics, Inc.

What the insiders did Net selling

By person